Sanofi (SNY) is a FR-listed Healthcare company in Drug Manufacturers - General with a market capitalization of
05.5B, trading at $43.88 on the NASDAQ. This SniperIQ fundamentals page covers Sanofi's valuation (P/E 12.4x, P/B 1.3x), profitability (net margin 16.0%), revenue (€46.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Market Cap
05.5B
P/E (TTM)12.4x
Net Margin16.0%
Revenue (FY25)€46.7B
Full research coverage
8-Quarter Revenue & Margin Trend
Debt Maturity & Coverage
Peer Valuation Comparison
Free Cash Flow & Owner Earnings
AI Signal + Institutional Flow
DCF Valuation Model
Frequently Asked Questions
What is Sanofi's market cap?
Sanofi (SNY) has a market capitalization of approximately
05.5B, trading at $43.88 on the NASDAQ. Market cap moves with the live share price.
What is Sanofi's P/E ratio?
Sanofi's trailing twelve-month P/E ratio is 12.4x, with a price-to-book (P/B) of 1.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Sanofi?
Sanofi runs a net profit margin of 16.0%, a gross margin of 71.9%, and an operating margin of 19.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sanofi generate?
Sanofi reported revenue of €46.7B for fiscal year 2025, with net income of €7.8B and earnings per share (EPS) of 3.2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sanofi pay a dividend?
Sanofi offers a trailing dividend yield of about 5.4%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Sanofi financially healthy?
Sanofi carries a debt-to-equity ratio of 0.27x and a current ratio of 1.01x, with a market beta of 0.28. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sanofi a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sanofi (SNY) the key facts are: market cap
05.5B, P/E 12.4x, revenue €46.7B, 52-week range 40.89-52.68. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Sanofi's full fundamentals live
Get Sanofi's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.